{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:23:17Z","timestamp":1787008997870,"version":"build-2736575974"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100003921","name":"Australian Government Department of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1176131"],"award-info":[{"award-number":["1176131"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2034002"],"award-info":[{"award-number":["2034002"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,15]]},"DOI":"10.1093\/infdis\/jiaf652","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:39:54Z","timestamp":1768480794000},"page":"802-805","source":"Crossref","is-referenced-by-count":3,"title":["When Time Is of the Essence: Hepatitis C Virus RNA Point-of-Care Testing in 15\u2005Minutes Becomes a Reality"],"prefix":"10.1093","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8657-4261","authenticated-orcid":false,"given":"Tanya L","family":"Applegate","sequence":"first","affiliation":[{"name":"The Kirby Institute, University of New South Wales , Sydney, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1833-2017","authenticated-orcid":false,"given":"Jason","family":"Grebely","sequence":"additional","affiliation":[{"name":"The Kirby Institute, University of New South Wales , Sydney, New South Wales ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026051419573003800_jiaf652-B1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2471\/BLT.23.289676","article-title":"Elimination and eradication goals for communicable diseases: a systematic review","volume":"101","author":"Khawar","year":"2023","journal-title":"Bull World Health Organ"},{"key":"2026051419573003800_jiaf652-B2","doi-asserted-by":"crossref","first-page":"p2181","DOI":"10.1136\/bmj.p2181","article-title":"Ending communicable diseases requires a combined elimination framework","volume":"382","author":"Ramos-Horta","year":"2023","journal-title":"BMJ"},{"key":"2026051419573003800_jiaf652-B3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/a-1777-6112","article-title":"A global systematic review of hepatitis C elimination efforts through micro-elimination","volume":"42","author":"Lazarus","year":"2022","journal-title":"Semin Liver Dis"},{"key":"2026051419573003800_jiaf652-B4","volume-title":"Global health sector strategy on viral hepatitis 2016\u20132021. Towards ending viral hepatitis","author":"World Health Organization (WHO)","year":"2021"},{"key":"2026051419573003800_jiaf652-B5","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/HEP.0000000000000779","article-title":"Feasibility of hepatitis C elimination by screening and treatment alone in high-income countries","volume":"80","author":"Tian","year":"2024","journal-title":"Hepatology"},{"key":"2026051419573003800_jiaf652-B6","volume-title":"Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022\u20132030","author":"World Health Organization (WHO)","year":"2022"},{"key":"2026051419573003800_jiaf652-B7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-med-050223-111239","article-title":"Global elimination of hepatitis C virus","volume":"76","author":"Fleurence","year":"2025","journal-title":"Annu Rev Med"},{"key":"2026051419573003800_jiaf652-B8","doi-asserted-by":"crossref","first-page":"103917","DOI":"10.1016\/j.drugpo.2022.103917","article-title":"Interventions to enhance testing and linkage to treatment for hepatitis C infection for people who inject drugs: a systematic review and meta-analysis","volume":"111","author":"Cunningham","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2026051419573003800_jiaf652-B9","article-title":"Targets of protective immunity and opportunities in hepatitis C virus vaccine development","author":"Park","year":"2025","journal-title":"Nat Rev Immunol"},{"key":"2026051419573003800_jiaf652-B10","doi-asserted-by":"crossref","first-page":"100522","DOI":"10.1016\/j.clinme.2025.100522","article-title":"Hepatitis C: current treatments, emerging therapies and tackling health inequities on the path to global elimination","volume":"25","author":"Farooq","year":"2025","journal-title":"Clin Med (Lond)"},{"key":"2026051419573003800_jiaf652-B11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/cid\/ciaf335","article-title":"Executive summary: state-of-the-art review: hepatitis C","volume":"81","author":"Lo Re","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026051419573003800_jiaf652-B12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaf367","article-title":"Right test for the right patient in the right setting: enhancing testing and treatment for hepatitis C infection among people who inject drugs [manuscript published online ahead of print 15 July 2025]","author":"Grebely","year":"2025","journal-title":"Clin Infect Dis"},{"key":"2026051419573003800_jiaf652-B13","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/14737159.2017.1400385","article-title":"Hepatitis C point-of-care diagnostics: in search of a single visit diagnosis","volume":"17","author":"Grebely","year":"2017","journal-title":"Exp Rev Mol Diagnos"},{"key":"2026051419573003800_jiaf652-B14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2468-1253(25)00068-8","article-title":"A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles","volume":"10","author":"Hiebert-Suwondo","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026051419573003800_jiaf652-B15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/cid\/ciae155","article-title":"Point-of-care testing for hepatitis C in the priority settings of mental health, prisons, and drug and alcohol facilities\u2014the PROMPt study","volume":"79","author":"McCartney","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026051419573003800_jiaf652-B16","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.3390\/diagnostics15222845","article-title":"Advances in point-of-care infectious disease diagnostics: integration of technologies, validation, artificial intelligence, and regulatory oversight","volume":"15","author":"Kardjadj","year":"2025","journal-title":"Diagnostics (Basel)"},{"key":"2026051419573003800_jiaf652-B17","doi-asserted-by":"crossref","first-page":"S342","DOI":"10.1093\/infdis\/jiad463","article-title":"Molecular point-of-care testing for hepatitis C: available technologies, pipeline, and promising future directions","volume":"229","author":"Ivanova Reipold","year":"2024","journal-title":"J Infect Dis"},{"key":"2026051419573003800_jiaf652-B18","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/cid\/ciad503","article-title":"The urgent need to implement point-of-care RNA testing for hepatitis C virus to support elimination","volume":"78","author":"Kapadia","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026051419573003800_jiaf652-B19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.idc.2018.02.010","article-title":"Hepatitis C virus diagnosis and the holy grail","volume":"32","author":"Applegate","year":"2018","journal-title":"Infect Dis Clin North Am"},{"key":"2026051419573003800_jiaf652-B20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41564-018-0295-3","article-title":"REASSURED diagnostics to inform disease control strategies, strengthen health systems and improve patient outcomes","volume":"4","author":"Land","year":"2019","journal-title":"Nat Microbiol"},{"key":"2026051419573003800_jiaf652-B21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2468-1253(22)00346-6","article-title":"Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis","volume":"8","author":"Trickey","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026051419573003800_jiaf652-B22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1186\/s12879-017-2770-5","article-title":"Optimising diagnosis of viraemic hepatitis C infection: the development of a target product profile","volume":"17","author":"Ivanova Reipold","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2026051419573003800_jiaf652-B23","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1093\/infdis\/jiac049","article-title":"Diagnostic accuracy of assays using point-of-care testing or dried blood spot samples for the determination of hepatitis C virus RNA: a systematic review","volume":"226","author":"Catlett","year":"2022","journal-title":"J Infect Dis"},{"key":"2026051419573003800_jiaf652-B24","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1093\/infdis\/jiaa037","article-title":"Time to detection of hepatitis C virus infection with the Xpert HCV viral load fingerstick point-of-care assay: facilitating a more rapid time to diagnosis","volume":"221","author":"Grebely","year":"2020","journal-title":"J Infect Dis"},{"key":"2026051419573003800_jiaf652-B25","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1186\/s12879-025-12004-z","article-title":"A point-of-care testing intervention to improve hepatitis C diagnosis and treatment uptake among people attending Aboriginal community controlled health services: the SCALE-C study","volume":"25","author":"Hosseini-Hooshyar","year":"2025","journal-title":"BMC Infect Dis"},{"key":"2026051419573003800_jiaf652-B26","doi-asserted-by":"crossref","first-page":"103982","DOI":"10.1016\/j.drugpo.2023.103982","article-title":"Single-visit hepatitis C point-of-care testing, linkage to nursing care, and peer-supported treatment among people with recent injecting drug use at a peer-led needle and syringe program: the TEMPO Pilot Study","volume":"114","author":"Grebely","year":"2023","journal-title":"Int J Drug Policy"},{"key":"2026051419573003800_jiaf652-B27","doi-asserted-by":"crossref","first-page":"104317","DOI":"10.1016\/j.drugpo.2024.104317","article-title":"Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facility","volume":"125","author":"MacIsaac","year":"2024","journal-title":"Int J Drug Policy"},{"key":"2026051419573003800_jiaf652-B28","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1093\/infdis\/jiy114","article-title":"Evaluation of the Xpert HCV viral load finger-stick point-of-care assay","volume":"217","author":"Lamoury","year":"2018","journal-title":"J Infect Dis"},{"key":"2026051419573003800_jiaf652-B29","first-page":"373","article-title":"HCV testing and linkage to care for hepatitis C virus infection for marginalized drug user populations attending a harm reduction service in Bologna, Italy","volume":"32","author":"Pavarin","year":"2024","journal-title":"Infez Med"},{"key":"2026051419573003800_jiaf652-B30","doi-asserted-by":"crossref","first-page":"104871","DOI":"10.1016\/j.drugpo.2025.104871","article-title":"Patient preferences for simplified hepatitis C testing modalities among people at risk of hepatitis C infection in Australia: the SELECT study","volume":"143","author":"Stevens","year":"2025","journal-title":"Int J Drug Policy"},{"key":"2026051419573003800_jiaf652-B31","first-page":"823","article-title":"Development of a rapid automated point-of-care test for hepatitis C viral RNA on the DASH rapid polymerase chain reaction system","volume":"233","author":"Reed","year":"2026","journal-title":"J Infect Dis"},{"key":"2026051419573003800_jiaf652-B32","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugpo.2018.08.011","article-title":"Acceptability and preferences of point-of-care finger-stick whole-blood and venepuncture hepatitis C virus testing among people who inject drugs in Australia","volume":"61","author":"Bajis","year":"2018","journal-title":"Int J Drug Policy"},{"key":"2026051419573003800_jiaf652-B33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tube.2016.09.002","article-title":"Highly sensitive sequence specific qPCR detection of Mycobacterium tuberculosis complex in respiratory specimens","volume":"101","author":"Reed","year":"2016","journal-title":"Tuberculosis (Edinb)"},{"key":"2026051419573003800_jiaf652-B34","author":"McFall"},{"key":"2026051419573003800_jiaf652-B35","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2468-1253(17)30075-4","article-title":"Evaluation of the Xpert HCV viral load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study","volume":"2","author":"Grebely","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026051419573003800_jiaf652-B36","doi-asserted-by":"crossref","unstructured":"Freiman JM, Wang J, Easterbrook PJ, et al \u00a0Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: analysis of a global dataset. J Hepatol \u00a02019; 71:62\u201370.","DOI":"10.1016\/j.jhep.2019.02.011"},{"key":"2026051419573003800_jiaf652-B37","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.jhep.2020.08.018","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series","volume":"73","author":"European Association for the Study of the Liver","year":"2020","journal-title":"J Hepatol"},{"key":"2026051419573003800_jiaf652-B38","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3390\/diagnostics12051255","article-title":"Diagnostic accuracy of point-of-care HCV viral load assays for HCV diagnosis: a systematic review and meta-analysis","volume":"12","author":"Tang","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026051419573003800_jiaf652-B39","volume-title":"Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection","author":"World Health Organization (WHO)","year":"2018"},{"key":"2026051419573003800_jiaf652-B40","first-page":"100750","article-title":"Optimizing point-of-care testing strategies for diagnosis and treatment of hepatitis C virus infection in Australia: a model-based cost-effectiveness analysis","volume":"36","author":"Shih","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"2026051419573003800_jiaf652-B41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1186\/s12879-024-10214-5","article-title":"Pre-market health systems barriers and enablers to infectious diseases point-of-care diagnostics in Australia: qualitative interviews with key informants","volume":"24","author":"Lafferty","year":"2024","journal-title":"BMC Infect Dis"},{"key":"2026051419573003800_jiaf652-B42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/bios12020124","article-title":"REASSURED multiplex diagnostics: a critical review and forecast","volume":"12","author":"Otoo","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"2026051419573003800_jiaf652-B43","first-page":"974","article-title":"Point-of-care testing for hepatitis C infection: a critical building block for the foundation to achieve elimination","volume":"79","author":"Grebely","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026051419573003800_jiaf652-B44","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2024.2403091","article-title":"Paving the way for quality assured, decentralised point-of-care testing for infectious disease in primary care\u2014real world lessons from remote Australia [manuscript published online ahead of print 24 December 2024]","author":"Applegate","year":"2024","journal-title":"Expert Rev Mol Diagn"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiaf652\/66540052\/jiaf652.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/5\/802\/66540052\/jiaf652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/233\/5\/802\/66540052\/jiaf652.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:57:39Z","timestamp":1778803059000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/233\/5\/802\/8438328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":44,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,1,22]]},"published-print":{"date-parts":[[2026,5,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiaf652","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5,15]]},"published":{"date-parts":[[2026,1,22]]}}}